Thermo FisherUS8835561023TMOTMO
Financials
Market Cap
$206.71B5Y beta
0.81EPS (TTM)
$15.45Free Float
381.02MP/E ratio (TTM)
35.05Revenue (TTM)
$42.86BEBITDA (TTM)
$10.76BFree Cashflow (TTM)
$6.40BPricing
Analyst Ratings
The price target is $608.10 and the stock is covered by 25 analysts.
Buy
16
Hold
9
Sell
0
Information
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.